Notwithstanding, the role of NOD1 in AD could be extended to the suppression of adipocyte differentiation and expression of nuclear receptors such as PPARγ, as well as CCAAT/enhancer binding protein-α, fatty acid binding protein-4, and leptin [56]. This evidence concerns the gene PPARG and Alzheimer disease.